**Must do**
1. **Square, three more seeds** (e.g., 45-47) for regime, random, and rule-based, all arms on the same seeds, giving 6 total. Fix the count before running and report every seed.
2. **NMI diagnostics per arm:** NMI at t=0, through Stage 2, and at the final checkpoint, plus expert utilization and prototype norms and distances. Use existing logs if they have this. Otherwise rerun with logging.

**Should do**
3. **Can, the same three extra seeds**, if compute allows. Regime is numerically ahead there, so this shows whether that gain is real.
4. **Rollouts per seed from 50 to 100-200** on the final checkpoints. Evaluation is cheap, and this tightens each seed's estimate.

**Optional**
5. **An oracle-routing arm**, routing by rule-derived phase labels. It shows whether routing quality can affect success at all in your architecture, which makes the null interpretable.

**Skip**
- LAR-MoE baseline
- More tasks
- More seeds for Softmax, which stays at 3

Whether three seeds is enough depends on which claim you're making.

**Routing stability: three seeds is defensible.** NMI of 0.5-0.67 vs 0.07-0.09 and switch rate of 0.04-0.07 vs 0.10-0.11 are huge gaps. Just report the per-seed values so readers can see they're consistent.

**"Stable routing doesn't improve success": three seeds can't carry it.** That is a claim that something didn't happen. With 3 seeds, the smallest possible two-sided sign-test p is 0.25 even if regime wins all three, and per-seed spreads like Can's 0.66/0.82/0.80 are wide. The most 3 seeds can support is "we did not detect a gain," and a reviewer will read it that way.

**Your idea of adding seeds only to random and warm-start doesn't fix this.** Your claim is about the regime arm, and its noise is what limits the comparison. Extra seeds on the controls barely help if regime stays at 3. It also breaks the seed-matched pairing, and adding seeds to only some arms after seeing results looks like selective stopping.

**Minimum I'd do**
1. Run new seeds on Square first, since that's where your counterexample lives. Give all three matched arms (regime, random, rule-based) the same new seeds, for example 45-47, to reach 6 total. Six also matters because it's the smallest count where an exact sign test can reach p<0.05 (5/5 gives 0.0625).
2. Keep the Softmax diagnostic at 3 seeds, since it isn't part of the matched comparison.
3. Decide the seed count before you run, report every seed, and don't stop early on a favorable result.
4. Then do Can, because regime is numerically ahead there. If that gain is real, your story becomes "sometimes it helps" instead of "it doesn't imply."
5. Cheaply, raise rollouts per seed from 50 to 100-200. Evaluation is much cheaper than training and tightens each seed's estimate. It doesn't fix seed-to-seed variance, so it supplements extra seeds and can't replace them.

If compute is really tight, Square with three arms × 3 extra seeds is the single most valuable addition. It's your decision. Just know that with 3 seeds the paper's success claim should stay "not detected," not "does not imply."

You're right on two points, but my verdict stands, for a different reason than before.

**Where I was wrong**

- **I judged an analysis paper by method-paper standards.** A LAR-MoE-style baseline matters if you're claiming a better method. You're not, so drop it as a requirement. Related work still has to be cited and distinguished, because the intro sentence about "not using demonstration structure" was factually contradicted by prior work. That's positioning, not a baseline.
- **I called your base policy weak without knowing your setup.** I compared your success rates to published Diffusion Policy numbers, which use different architectures and data budgets, and I didn't know it was vision-based. Absolute success matters less than having headroom and variance, which your task selection addresses. State the limitation, but don't chase SOTA.

**Where I hold my ground.** Your claim is that stable routing doesn't imply better performance. "X does not imply Y" needs a demonstrated counterexample, so the burden falls on showing that regime initialization did not improve success. Square is your counterexample, but the current evidence can't establish it. On Square, regime vs rule-based is −4.7 points, and the 95% interval upper bound is about +6 points. vs random it is −1.3 points, with an upper bound near +9. Those bounds are conditional on the rollouts and ignore seed-to-seed variance, so across retraining seeds they're much wider. On Can, regime is numerically ahead. So the honest claim today is "we did not detect a gain," not "stable routing doesn't buy performance."

That makes seeds the real bottleneck. Five to ten seeds on Can and Square would turn a suggestive counterexample into a bounded one, and that's what an ICLR reviewer would judge your central claim on. An oracle-routing arm is optional. It isn't a comparison to others, it would tell you whether routing quality can matter in this architecture at all, which makes the null interpretable.

**Two things to check about your own paper**
1. You describe Stage 1 as a dynamic topological method that learns phases automatically. The files, as the agent read them, show Stage-1 latents trained with rule-derived phase labels (cross-entropy and SupCon), with NMI measured against those labels. If that's accurate, "automatic" needs the qualification we drafted. Please confirm which is true.
2. The patches describe regime discovery as change-point segmentation plus clustering. If your topological method is your own and does something more, the patches undersell it. But then it needs its own evaluation as a contribution.

**Verdict.** I still wouldn't submit to the main track unless you can get 5+ seeds on both tasks and the step-0 NMI diagnostic before Sep 25, and the abstract deadline may already be past. Otherwise, post the preprint, run those experiments, and aim for a workshop or a later cycle. The idea is sound and the honest framing is a strength. The current sample just can't carry the central claim.

**No, I wouldn't submit this to ICLR's main track.** This is my judgment from the abstract, introduction, and patches. I haven't seen the full manuscript, and I can't predict reviews.

**Why not.** The claims you can now honestly make are narrow: large offline routing differences, and success differences that aren't statistically resolved. The evidence behind them is thin, and a reviewer can see that right away:
- three seeds
- two informative tasks
- a weak, memoryless base policy
- no empirical comparison to LAR-MoE-style routing or an oracle-routing arm
- an unexplained rule-init result
- NMI measured against the same phase vocabulary that shaped the representation

Careful wording fixes the overclaiming but not those gaps, and I'd expect a reject or weak reject.

**What a reject costs.** ICLR reviews are public on OpenReview. Per one summary of the guidelines, papers withdrawn after the deadline stay publicly visible, so withdrawing isn't a clean exit. Every submission also needs an author registered to review at least three papers, which is a real time cost. The upside is a small chance at a main-track paper with reviews you'd probably get anyway from a better-targeted venue.

**Timing.** The official pages list the abstract deadline as Sep 18 and the paper deadline as Sep 25 (AOE), while one page says Sept 11 and Sept 16. Sep 18 AOE ends at 11:59 UTC on Sep 19. If you haven't registered an abstract, the decision may already be made, since no authors can be added after that deadline.

**The one scenario where I'd reconsider.** You've registered an abstract, and you can finish these before Sep 25:
- 5–10 seeds
- the t=0 and training-curve diagnostic
- an oracle-routing arm
- one LAR-MoE-style baseline

Even then I'd call it a long shot, and I wouldn't rush it for a paper that's clearly improvable.

**What I'd do instead**
1. Apply the text patches and post an arXiv preprint. ICLR permits this.
2. Run the experiments above over the next 1–2 months.
3. Target a workshop or robot-learning venue. ICRA's deadline was Sep 15, so it's closed. ICLR workshops have a suggested contribution deadline around Feb 1, 2027, but the workshop list isn't finalized (acceptances go out Nov 29). I haven't verified other venues' dates.
4. Reassess a main-track submission for a later cycle if the added evidence shows a clear effect, or a well-powered null with an explanatory mechanism.

The honest framing you now have is a strength, and a well-powered version of this study could be worth publishing. It isn't there yet, and submitting early would make the reviews public before it is.

**Mostly yes.** The text now matches the evidence. It fixes the points I raised earlier:
- the "persists" wording is gone
- "dissociation" and "task-dependent" are gone
- the NMI kinematic-circularity limitation is added
- the step-0 diagnostic is required
- a note on task selection is added

The margin-loss distinction (disabled in the matched ablation, active in the full configuration) is a useful new catch. "Peng et al." for PADD checks out: the ICML 2026 authors are Xinyue Peng et al., and its Stage I clusters teacher neurons to seed student experts, as the patch says. I haven't seen the manuscript, so the claims about λ_m=0 versus the full configuration, 50 rollouts per seed, and the `phase`/`phase_topo` labels rest on the agent's reading of your files. Check those yourself.

**What still needs fixing**

1. **The abstract's last sentence smuggles the conclusion back in.** "Should be evaluated separately" reads as if the data showed a dissociation. Try: "With three seeds, the study cannot determine whether these offline differences translate into closed-loop gains."
2. **The introduction replacement dropped its citations.** The earlier version had Mazza, Rodriguez, and Deng, and this one has none. Restore them.
3. **The Mazza entry is inconsistent.** It uses the original title with an arXiv link that now resolves to the retitled version. Cite a specific version and match the title to it.
4. **State when Can and Square were selected.** The disclosure says they "retained outcome variation," but not whether that judgment came from baseline results before the initialization ablation or after seeing its outcomes. A reader worried about cherry-picking will ask.
5. **A base-policy limitation is missing.** Square success of roughly 27–35%, near-zero results on two tasks, and a memoryless policy mean a null could reflect expert or policy capacity, not routing. Say so.
6. **Say which configuration the headline method is.** Regimes are used only for initialization in the ablation, but the full configuration has an ongoing rule-phase margin loss. That is closer to supervised phase routing, which weakens the novelty contrast for the headline method. The "initialization-only" claim applies only to the ablation, and the paper should say so plainly.
7. **Dropping the "±10 points" statement hides the low power.** I agree it shouldn't appear as a generic number, since it's conditional on rollouts. But include the paired-difference intervals, with the pooled ones labeled as conditional and the seed-level ranges shown, so readers can see what the design excludes. "Descriptive" shouldn't obscure that.
8. **Say the rule-init NMI result is unexplained.** Rule-based initialization scoring about the same as random needs an explicit sentence, and the t=0 diagnostic is what would resolve it.

**Bottom line.** The text will be defensible after these edits. The evidence gap is unchanged: three seeds, two informative tasks, a weak base policy, and no empirical comparison to LAR-MoE-style routing or an oracle-routing arm. Honest wording makes this a solid workshop or preprint paper, but it doesn't add the evidence an ICLR main-track reviewer would expect.